BEONE MEDICINES LTD. (BEIGF) Total liabilities 2016–2025
BEONE MEDICINES LTD. (BEIGF) total liabilities at each fiscal year-end, per SEC filings.
$3.8BFY2025 · since FY2016: $52.9M → $3.8B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.8B | +47.9% |
| FY2024 | $2.6B | +14.1% |
| FY2023 | $2.3B | +13.6% |
| FY2022 | $2.0B | -16.9% |
| FY2021 | $2.4B | +38.8% |
| FY2020 | $1.7B | +173.1% |
| FY2019 | $633.9M | +27.8% |
| FY2018 | $496.0M | +36.9% |
| FY2017 | $362.2M | +584.7% |
| FY2016 | $52.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More BEIGF financial trends
BEIGF RevenueBEIGF Net incomeBEIGF Net marginBEIGF Gross profitBEIGF Gross marginBEIGF Operating incomeBEIGF Operating marginBEIGF Operating cash flowBEIGF Free cash flowBEIGF Capital expendituresBEIGF Return on equityBEIGF Stock buybacksBEIGF Dividends paidBEIGF Total assetsBEIGF Shareholders’ equityBEIGF overview →